| Literature DB >> 20967274 |
Solomon Chih-Cheng Chen1, Jun-Jun Yeh, Mei-Hwei Chang, Yu-Kuei Liao, Li-Chen Hsiao, Choo-Aun Neoh, Teck-Siang Tok, Jung-Der Wang.
Abstract
BACKGROUND: To explore the gender difference of ALT elevation and its association with high hemoglobin levels.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20967274 PMCID: PMC2953507 DOI: 10.1371/journal.pone.0013269
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Basic information including age, anthropometric measurements, biochemical data and hepatitis B antibody status of 3547 adolescents stratified by gender.
| Male | Female |
| |
| Number (%) | 1542 (43.5) | 2005 (56.5) | |
| Age (mean ± S.D.), years | 16.6±1.6 | 16.4±1.0 | 0.675 |
| Body height (mean ± S.D.), cm | 170.4±6.3 | 159.4±5.5 | <0.001 |
| Body weight (mean ± S.D.), kg | 63.8±14.4 | 52.7±9.8 | <0.001 |
| BMI (mean ± S.D.) | 21.9±4.5 | 20.7±3.6 | <0.001 |
| <24, n (%) | 1161 (75.3) | 1724 (86.0) | <0.001 |
| 24 – 26.9, n (%) | 176 (11.4) | 157 (7.8) | |
| ≥27, n (%) | 205 (13.3) | 124 (6.2) | |
| ALT (mean ± S.D.), U/L | 19.2±15.3 | 14.4±8.7 | <0.001 |
| >42 U/L, n (%) | 83 (5.4) | 29 (1.4) | <0.001 |
| ≤42 U/L, n (%) | 1459 (94.6) | 1976 (98.6) | |
| Hemoglobin (mean ± S.D.), g/dl | 14.8±1.1 | 13.1±1.3 | <0.001 |
| Cholesterol (mean ± S.D.), mg/dl | 157.6±29.3 | 174.6±30.2 | <0.001 |
| >200 mg/dl, n (%) | 116 (7.5) | 354 (17.7) | <0.001 |
| ≤200 mg/dl, n (%) | 1426 (92.5) | 1651 (82.3) | |
| Anti-HBs antibody positive, n (%) | 521 (33.8) | 765 (38.2) | 0.007 |
| Antibody negative, n (%) | 1021 (66.2) | 1240 (61.8) |
Student t-test or Chi square test, with p value <0.05 as significant.
BMI = body mass index.
ALT = alanine aminotransferase.
AST = aspartate aminotransferase.
S.D. = standard deviation.
Figure 1The distribution of alanine aminotransferase (ALT) levels by hemoglobin levels among 3547 adolescents.
Two fitting regression lines of two genders are drawn by cubic equation with statistical significance, p<0.001.
Figure 2The cumulative number of individuals with abnormal ALT has a linear correlation with the hemoglobin levels for both genders, with both regression lines being statistically significant.
The slope of the regression line is higher for males than for females: 22.95 vs. 6.27. According to the regression lines, the hemoglobin levels at which the cumulative number of abnormal ALT would be zero, are about 11.0 g/dl for females and 13.5 g/dl for males.
Figure 3The proportion of individuals with abnormal alanine aminotransferase (ALT), categorized by body mass index (BMI) and quintiles of hemoglobin levels by gender.
The total numbers of individuals with abnormal ALT are 29 and 83 cases among 2005 females and 1542 males, respectively.
Comparisons of odds ratio (OR) and 95% confidence interval (95%CI) for risk factors associated with elevated alanine aminotransferase (ALT) among different logistic regression models.
| ALT, U/L>42/≤42 | Model 1 = All subjectsOR (95%CI) | Model 2A = Male adolescentsOR (95%CI) | Model 2B = Female adolescentsOR (95%CI) | |
| Gender | ||||
| Female | 29/1976 | 1 | ||
| Male | 83/1459 |
| ||
| Body mass index, kg/m2 | ||||
| <24 | 24/2885 | 1 | 1 | 1 |
| 24–26.9 | 15/333 |
|
|
|
| ≥27 | 73/329 |
|
|
|
| Cholesterol, mg/dl | ||||
| ≤200 | 83/2994 | 1 | 1 | 1 |
| >200 | 29/441 |
| 1.5 (0.8–2.8) |
|
| Hemoglobin, g/dl | ||||
| Q1 | 11/699 | 1 | 1 | 1 |
| Q2 | 16/691 | 1.4 (0.6–3.1) | 1.3 (0.4–3.8) | 1.6 (0.5–5.0) |
| Q3 | 14/696 | 1.0 (0.4–2.3) | 1.6 (0.6–4.5) | 0.4 (0.1–1.9) |
| Q4 | 22/685 | 1.3 (0.6–2.8) | 1.8 (0.7–4.9) | 0.7 (0.2–2.6) |
| Q5 | 49/664 |
|
| 1.4 (0.5–4.6) |